Literature DB >> 10344412

Measuring central-chemoreflex sensitivity in man: rebreathing and steady-state methods compared.

R M Mohan1, C E Amara, D A Cunningham, J Duffin.   

Abstract

We compared the central-chemoreflex sensitivities estimated from steady-state tests with those estimated from rebreathing tests in five subjects. In one laboratory, each subject underwent nine dynamic end-tidal forcing experiments. Three repetitions of 3, 6 and 9 mmHg step changes in the end-tidal partial pressure of carbon dioxide, from a pre-step partial pressure 1.5 mmHg above resting, were used to establish four points of the steady-state ventilatory response to carbon dioxide. In another laboratory, each subject underwent two rebreathing experiments, one using Read's rebreathing technique and the other a modified rebreathing method which included a prior hyperventilation. The central-chemoreflex sensitivities, estimated from the slopes of the ventilatory responses to carbon dioxide using different combinations of the four steady-state points. were compared to those estimated from the slopes of the rebreathing responses. The steady-state sensitivities were significantly lower than the Read rebreathing sensitivities. The ratio of modified rebreathing sensitivities to steady-state sensitivities was closest to one when steady-state sensitivities were estimated from the two middle points of the ventilatory responses. The mean (SE) ratio of the sensitivities was 1.22 (0.21) in this case. We identify a number of factors that may affect the estimation of central-chemoreflex sensitivity using each technique. These include a maximum limit of the ventilation response at high partial pressures of carbon dioxide, an inability to sustain high ventilation for the duration of the steady-state tests and the inclusion of parts of the ventilatory response whose carbon dioxide partial pressures lie below the central-chemoreflex threshold. We conclude that the modified rebreathing method provides the best estimate of central-chemoreflex sensitivity of the three methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344412     DOI: 10.1016/s0034-5687(99)00003-1

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  21 in total

1.  Repeated hypoxic exposures change respiratory chemoreflex control in humans.

Authors:  S Mahamed; J Duffin
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

2.  Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males.

Authors:  Jason H Mateika; Qasim Omran; J A Rowley; X S Zhou; M P Diamond; M Safwan Badr
Journal:  J Physiol       Date:  2004-09-16       Impact factor: 5.182

3.  Measuring the ventilatory response to hypoxia.

Authors:  James Duffin
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

4.  Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers.

Authors:  Geoffrey Mukwaya; Thomas MacGregor; David Hoelscher; Thomas Heming; Daniel Legg; Kelli Kavanaugh; Phillip Johnson; John P Sabo; Scott McCallister
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Adaptation of the respiratory controller contributes to the attenuation of exercise hyperpnea in endurance-trained athletes.

Authors:  Tadayoshi Miyamoto; Masashi Inagaki; Hiroshi Takaki; Toru Kawada; Toshiaki Shishido; Atsunori Kamiya; Masaru Sugimachi
Journal:  Eur J Appl Physiol       Date:  2011-05-03       Impact factor: 3.078

6.  Ventilatory baroreflex sensitivity in humans is not modulated by chemoreflex activation.

Authors:  Julian M Stewart; Eileen Rivera; Debbie A Clarke; Ila L Baugham; Anthony J Ocon; Indu Taneja; Courtney Terilli; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-11       Impact factor: 4.733

7.  Differences in the control of breathing between Himalayan and sea-level residents.

Authors:  M Slessarev; E Prisman; S Ito; R R Watson; D Jensen; D Preiss; R Greene; T Norboo; T Stobdan; D Diskit; A Norboo; M Kunzang; O Appenzeller; J Duffin; J A Fisher
Journal:  J Physiol       Date:  2010-03-01       Impact factor: 5.182

8.  Cerebral vasomotor reactivity during hypo- and hypercapnia across the adult lifespan.

Authors:  Tsubasa Tomoto; Jonathan Riley; Marcel Turner; Rong Zhang; Takashi Tarumi
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-15       Impact factor: 6.200

9.  Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.

Authors:  Jui-Lin Fan; Keith R Burgess; Kate N Thomas; Samuel J E Lucas; James D Cotter; Bengt Kayser; Karen C Peebles; Philip N Ainslie
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

10.  Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes.

Authors:  Yoseph Mebrate; Keith Willson; Charlotte H Manisty; Resham Baruah; Jamil Mayet; Alun D Hughes; Kim H Parker; Darrel P Francis
Journal:  J Appl Physiol (1985)       Date:  2009-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.